T
he Tn1331 transposon was the first member of the Tn3 subfamily reported to contain a structure of integron gene cassettes, with the attI1*-aac(6=)-Ib-attC aac(6=)-Ib -aadA1-attI1*-bla OXA-9 -attC blaOXA-9 array (1-5). The basic structure of a gene cassette consists of a gene and a recombination site (called attC), which can be targeted by integrases of integrons. The attC recombination sites are 57 to 141 bp long and are composed of 2 short regions of sequence similarity at their boundaries (1R to 2R and 1L to 2L) separated by a stretch (20 to 104 bp) of imperfect internal dyad symmetry (6) . attI1* in Tn1331 shows identity with 8 bp of the attI1 recombination site from class 1 integrons (2) .
It was previously shown that two point mutations (W87R and D164Y) (Fig. 1 ) within the aac(6=)-Ib gene confer the capability of the gene product to acetylate not only aminoglycosides but also the fluoroquinolones norfloxacin and ciprofloxacin (7) . This gene, named aac(6=)-Ib-cr, also known as aacA4-cr, is the first that encodes an enzyme able to inactivate two families of antibiotics (7) . Currently, this gene and the qnrB alleles are the prevalent plasmid-mediated quinolone resistance genes (8) .
Currently, six alleles of aac(6=)-Ib-cr have been identified, all as gene cassettes, with 5 of them generating amino acid changes at the protein level (7, (9) (10) (11) (12) (Fig. 1) . They have been found mainly in classical class 1 integrons (13, 14) and sporadically in gene cassette arrays with IS26 in the structures IS26-aac(6=)-Ib-cr1-bla OXA-30 -catB3-IS26 (GenBank accession no. AY458016), aac(3)-II-IS26-aac(6=)-Ib-cr2-bla OXA-1 (GenBank accession no. GQ438247), and aac(6=)-Ib-cr2-bla OXA-1 -⌬catB3-IS26-aac(3)-II (GenBank accession no. GQ438248) (15, 16) . In the plasmid pMdT1, the allele is not associated with other gene cassettes or integron-related sequences and appears to have inserted in a secondary site (12) .
Taking into account that the first isolation of gene cassettes embedded in Tn3, including aac(6=)-Ib, occurred in Argentina in the 1980s (GenBank accession no. AF479774.1) (1, 2, 4, 17-19), we decided to evaluate the evolution of Tn1331, focusing on the nucleotide sequence of aac(6=)-Ib to study the emergence of aac(6=)-Ib-cr within this genetic structure, due to its clinical importance.
We performed a retrospective study over 24 years in which we included 331 clinical isolates resistant to at least three families of antibiotics. The isolates belonged to 8 species from 5 hospitals in Argentina recovered since 1989. According to PCR mapping (Table 1), Tn1331 was found in 65% of Klebsiella pneumoniae (39/60), 14% of Serratia marcescens (4/28) (13) , plus a new additional point mutation (GAT to GTT at position 548) that encodes a valine as the penultimate amino acid, as found in Tn1331, instead of the aspartic acid encoded by aac(6=)-Ib-cr and most of the aac(6=)-Ib alleles (30/35) (7, 9-11, 13, 18) ( Fig. 1 ). Like the aac(6=)-Ib allele in Tn1331, aac(6=)-Ib-cr7 also contains a unique structure at the 5= end, consisting of attI1* and the nucleotides that encode the last six amino acids of bla TEM-1 (23) instead of the previously reported 5= aac(6=)-Ib-cr gene cassette variations (13) . To determine if Tn6238 was located in a transferable plasmid, we performed a biparental conjugation, as described before (24), with E. coli J53-AZ r (AZ r , azide resistant) as the recipient strain. The transconjugants were selected on Mueller-Hinton agar supplemented with sodium azide (100 g/ml) and ampicillin (25 g/ml). The transconjugant E. coli strain J53 KF7-TC6 showed the aminoglycoside and quinolone resistance profiles for aac(6=)-Ib-cr (Table 2) , with a difference of 6 mm between the inhibition zones of levofloxacin (LVX) and ciprofloxacin (CIP) in the disk diffusion method (⌬ LVX-CIP Ն 5), as described before (25) . Although the plasmid incompatibility group was not determined by replicon typing (26) , the presence of Tn6238 in the transconjugant was confirmed by PCR mapping. By sequencing this transconjugant with outward primers targeting the tnpA and bla TEM-1 genes, we determined that the inverted repeats (IRs) of Tn6238 were 100% identical to the IRs of Tn3 and Tn1331 (4, 27) . The In197 class 1 integron, which harbors the dfrA16c gene cassette (Integrall [http://integrall.bio.ua.pt/]), was also detected in the transconjugant by PCR mapping. The fact that this plasmid contains a Tn1331 derivative and a complete class 1 integron potentiates the exchange of gene cassettes between the two genetic platforms.
In order to further analyze the origin of aac(6=)-Ib-cr7, we performed a bioinformatic analysis of the aac(6=)-Ib-cr7 gene cassette and related sequences from GenBank (Fig. 1) . To perform the comparison, we selected the conserved region of the open reading frame (ORF) of each aac(6=)-Ib-cr allele, discarding the heterogeneous 5= end that generates N-terminal extensions of the encoded proteins (13) , and subsequently compared their attC sites. We (Fig. 1) . As expected, the attC aac(6=)-Ib-cr and attC aac(6=)-Ib sites are highly related, and there is one prevalent attC site, while the remaining are associated with only a few alleles. Nevertheless, some of the mutations in the attC sites may have an effect on the recombination efficiencies, since they disrupt the 2R/2L complementarity or generate an additional extrahelical base, thus affecting their dissemination ( Fig. 1) . In regard to aac(6=)-Ib-cr7 in Tn6238 and aac(6=)-Ib in the other Tn1331-related transposons, the 8-bp AA ACAAAG motif of the attI1* site located at the 5= end has a crucial effect in minimizing IntI1-mediated recombination (28) . The stability of the attI1*-aac(6=)-Ib-attC aac(6=)-Ib -aadA1-attI1*-bla OXA-9 -attC blaOXA-9 array in Tn1331 found in our isolates and others (14, 19, 20) reveals that the event that created Tn1331 is not very common. Based on this and the analyses showing that (i) the mutation that determines the D183V change in the AAC(6=)-Ib protein encoded in Tn1331 is not very frequent in aac(6=)-Ib found in class 1 integrons from GenBank or in Argentinian isolates (data not shown), (ii) the attC site is the same as the most frequent variant found in both Tn1331 from pMET and in class 1 integrons, (iii) the aac(6=)-Ib-cr variant found in Tn6238 has only the two mutations that lead to fluoroquinolone resistance, (iv) the excision of aac(6=)-Ib from Tn1331 by IntI1 is null or very low (28) , and (v) we could not discard homologous recombination with a transient aac(6=)-Ib-cr that would include only the region that contains both crucial mutations for the fluoroquinolone resistance phenotype, then our subsequent proposal is that the simplest explanation for the creation of Tn6238 that requires the minimum amount of events of mobilization and/or mutation and hence is the most likely is that both mutations leading to amino acid changes D164Y and W87R or even homologous recombination with a transient aac(6=)-Ib-cr2 have happened in the genetic platform of Tn1331 (Fig. 2) .
In conclusion, Tn1331 is frequent and stably maintained among fermenting bacilli in clinical isolates analyzed from Buenos Aires over 24 years, but it has the potential to increase its antimicrobial resistance background, as shown by the emergence of Tn6238. There are now seven alleles of aac(6=)-Ib-cr reported around the world. These alleles are spreading in two successful genetic platforms, class 1 integrons and Tn3-derivative transposons, in clinical bacterial isolates from Argentina (9, 25) . The emergence of Tn6238 shows how bacteria are able to acquire new resistance determinants and novel platforms that enhance the dissemination of antimicrobial resistance.
Nucleotide sequence accession number. The nucleotide sequences determined in this work have been submitted to the GenBank database and assigned accession no. KJ511462. The bioinformatics analysis has been performed using sequences from GenBank, National Center for Biotechnology Information (http: //www.ncbi.nlm.nih.gov/).
